Related Topic: Radiation

Study points to Mayak as source of ruthenium release

Study points to Mayak as source of ruthenium release

A used fuel reprocessing plant in the southern Urals region of Russia is the most likely source of a release of the isotope ruthenium-106 detected across Europe in late 2017, a study has concluded. No incident has, however, been reported at the Mayak facility or any other Russian nuclear facility and Rosatom has always maintained this.

Regulation & Safety 30 July 2019


Three US firms awarded Mo-99 production funds

Three US firms awarded Mo-99 production funds

The US Department of Energy's National Nuclear Security Administration has awarded cooperative agreements for the production of molybdenum-99 to three US companies. The announcement came as one of the companies - Shine Medical Technologies - submitted an application to the Nuclear Regulatory Commission to produce medical isotopes at its new production facility in Janesville, Wisconsin.

Regulation & Safety 23 July 2019


Viewpoint: Japan must avoid over-conservatism in clearance of material

Viewpoint: Japan must avoid over-conservatism in clearance of material

The Nuclear Regulation Authority of Japan is considering changes that would make the clearance of radioactive material about ten times stricter than international standards, creating unnecessary confusion and cost, writes Dr Charlotta Sanders, senior project manager at World Nuclear Association.

Perspectives 23 July 2019


Ukraine seeks to improve Chernobyl's image

Ukraine seeks to improve Chernobyl's image

Ukrainian President Volodymyr Zelensky has signed a decree that sets out plans to develop the Chernobyl exclusion zone as a site for tourism, including new walking trails and enhanced mobile phone reception.

Energy & Environment 12 July 2019


UK and China team up on environmental protection

UK and China team up on environmental protection

UK-based research and development company Innovative Physics Ltd and China Environmental Protection Company Ltd have signed an agreement on technologies and skills to further improve the safety of nuclear power plants in China and overseas.

Regulation & Safety 24 June 2019


Shine breaks ground for US medical isotope facility

Shine breaks ground for US medical isotope facility

Shine Medical Isotopes yesterday broke ground on its first medical isotope production facility in Janesville, Wisconsin. Commercial production of isotopes, including molybdenum-99 (Mo-99), is scheduled to begin in 2021.

New Nuclear 10 May 2019


Viewpoint: Sharing knowledge in European radwaste management

Viewpoint: Sharing knowledge in European radwaste management

All countries in Europe have a common interest in ensuring that radioactive waste management is done in a way that guarantees safety and security today and also in the long term, writes Charles McCombie, president of Arius Association.

Perspectives 12 April 2019


Researchers study Fukushima particle in close-up

Researchers study Fukushima particle in close-up

A joint team of UK and Japanese researchers have used the UK's synchrotron science facility to analyse the internal structure and composition of a radioactive particle collected from close to the damaged Fukushima Daiichi nuclear power plant in Japan.

Regulation & Safety 11 March 2019


Four US companies chosen for Mo-99 production funding

Four US companies chosen for Mo-99 production funding

The US Department of Energy's National Nuclear Security Administration has selected four companies to begin negotiations for potential new cooperative agreement awards for the supply of molybdenum-99 (Mo-99) without using highly enriched uranium.

Regulation & Safety 21 February 2019


NRG receives funding for nuclear medicine R&D centre

NRG receives funding for nuclear medicine R&D centre

The Advancing Nuclear Medicine consortium, led by the Nuclear Research and Consultancy Group, has been awarded a EUR6.8 million (USD7.7 million) subsidy to develop FIELD-LAB. This Dutch initiative is aimed at accelerating the development and introduction of new radiopharmaceuticals.

New Nuclear 18 January 2019